Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro

BACKGROUND: Everolimus (EVE), a mammalian target of rapamycin inhibitor, has been proposed as liver transplant immunosuppressive drug, gaining wide interest also for the treatment of cancer. Although an appropriate tolerance, it may induce several adverse effects, such as fibro-interstitial pneumoni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Masola, Valentina, Carraro, Amedeo, Zaza, Gianluigi, Bellin, Gloria, Montin, Umberto, Violi, Paola, Lupo, Antonio, Tedeschi, Umberto
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570634/
https://ncbi.nlm.nih.gov/pubmed/26369804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0347-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados